The number of new daily SARS-CoV-2 infections is frantically rising in almost every country of the EU. The phenomenological explanation offered is a new mutation of the virus, first identified in the UK. We use publicly available data in combination with a controlled SIR model, which captures the effects of preventive measures on the active cases, to show that the current wave of infections is consistent with a single transmission rate. This suggests that the new SARSCoV- 2 variant is as transmissible as previous strains. Our findings indicate that the relaxation of preventive measures is closely related with the ongoing surge in cases. We simulate the effects of new restrictions and vaccination campaigns in 2021, demonstrating that lockdow...
Individual variation in susceptibility and exposure is subject to selection by natural infection, ac...
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unpreced...
As a countermeasure to the SARS-CoV-2 pandemic, there has been swift development and clinical trial ...
The number of new daily SARS-CoV-2 infections experienced an abrupt increase during the last quarter...
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, VOC 202012/01 (lineage B.1.1...
In this paper, we estimate the path of daily SARS-CoV-2 infections in England from the beginning of ...
Self-instigated isolation is heavily relied on to curb severe acute respiratory syndrome coronavirus...
The dynamics of immunity are crucial to understanding the long-term patterns of the SARS-CoV-2 pande...
The introduction of COVID-19 vaccination passes (VPs) by many countries coincided with the Delta var...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
The continuous mutation of SARS-CoV-2 opens the possibility of the appearance of new variants of the...
Background: England's COVID-19 roadmap out of lockdown policy set out the timeline and conditions fo...
The dynamics of immunity are crucial to understanding the long-term patterns of the SARS-CoV-2 pande...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide crisis with prof...
Individual variation in susceptibility and exposure is subject to selection by natural infection, ac...
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unpreced...
As a countermeasure to the SARS-CoV-2 pandemic, there has been swift development and clinical trial ...
The number of new daily SARS-CoV-2 infections experienced an abrupt increase during the last quarter...
A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, VOC 202012/01 (lineage B.1.1...
In this paper, we estimate the path of daily SARS-CoV-2 infections in England from the beginning of ...
Self-instigated isolation is heavily relied on to curb severe acute respiratory syndrome coronavirus...
The dynamics of immunity are crucial to understanding the long-term patterns of the SARS-CoV-2 pande...
The introduction of COVID-19 vaccination passes (VPs) by many countries coincided with the Delta var...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
The English SARS-CoV-2 epidemic has been affected by the emergence of new viral variants such as B.1...
The continuous mutation of SARS-CoV-2 opens the possibility of the appearance of new variants of the...
Background: England's COVID-19 roadmap out of lockdown policy set out the timeline and conditions fo...
The dynamics of immunity are crucial to understanding the long-term patterns of the SARS-CoV-2 pande...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide crisis with prof...
Individual variation in susceptibility and exposure is subject to selection by natural infection, ac...
The development and deployment of several SARS-CoV-2 vaccines in a little over a year is an unpreced...
As a countermeasure to the SARS-CoV-2 pandemic, there has been swift development and clinical trial ...